Your browser doesn't support javascript.
loading
Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.
Mulpuru, Sunita; Li, Li; Ye, Lingyun; Hatchette, Todd; Andrew, Melissa K; Ambrose, Ardith; Boivin, Guy; Bowie, William; Chit, Ayman; Dos Santos, Gael; ElSherif, May; Green, Karen; Haguinet, Francois; Halperin, Scott A; Ibarguchi, Barbara; Johnstone, Jennie; Katz, Kevin; Langley, Joanne M; LeBlanc, Jason; Loeb, Mark; MacKinnon-Cameron, Donna; McCarthy, Anne; McElhaney, Janet E; McGeer, Allison; Powis, Jeff; Richardson, David; Semret, Makeda; Shinde, Vivek; Smyth, Daniel; Trottier, Sylvie; Valiquette, Louis; Webster, Duncan; McNeil, Shelly A.
Afiliação
  • Mulpuru S; Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, ON, Canada. Electronic address: smulpuru@toh.ca.
  • Li L; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Ye L; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Hatchette T; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Andrew MK; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Ambrose A; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Boivin G; Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada.
  • Bowie W; Faculty of Medicine, Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Chit A; Sanofi Pasteur, Swiftwater, PA; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
  • Dos Santos G; Business & Decision Life Sciences, Brussels, Belgium (GlaxoSmithKline).
  • ElSherif M; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Green K; Mount Sinai Hospital, Toronto, ON, Canada.
  • Haguinet F; GlaxoSmithKline, Wavre, Belgium.
  • Halperin SA; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Ibarguchi B; GlaxoSmithKline, Mississauga, ON, Canada.
  • Johnstone J; Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Katz K; North York General Hospital, Toronto, ON, Canada.
  • Langley JM; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • LeBlanc J; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • Loeb M; Division of Infectious Diseases, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
  • MacKinnon-Cameron D; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
  • McCarthy A; Ottawa Hospital Research Institute, Clinical Epidemiology Program, University of Ottawa, ON, Canada.
  • McElhaney JE; Health Sciences North Research Institute, Sudbury, ON, Canada.
  • McGeer A; Mount Sinai Hospital, Toronto, ON, Canada.
  • Powis J; Toronto East General Hospital, Toronto, ON, Canada.
  • Richardson D; William Osler Health System, Brampton, ON, Canada.
  • Semret M; Department of Medicine, Division of Infectious Diseases, Faculty of Medicine, McGill University, Montreal, QC, Canada.
  • Shinde V; GlaxoSmithKline, King of Prussia, PA.
  • Smyth D; The Moncton Hospital, Moncton, NB, Canada.
  • Trottier S; Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada.
  • Valiquette L; Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Webster D; Horizon Health, Saint John, NB, Canada.
  • McNeil SA; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada.
Chest ; 155(1): 69-78, 2019 01.
Article em En | MEDLINE | ID: mdl-30616737
ABSTRACT

BACKGROUND:

The effectiveness of influenza vaccination in reducing influenza-related hospitalizations among patients with COPD is not well described, and influenza vaccination uptake remains suboptimal.

METHODS:

Data were analyzed from a national, prospective, multicenter cohort study including patients with COPD, hospitalized with any acute respiratory illness or exacerbation between 2011 and 2015. All patients underwent nasopharyngeal swab screening with polymerase chain reaction (PCR) testing for influenza. The primary outcome was an influenza-related hospitalization. We identified influenza-positive cases and negative control subjects and used multivariable logistic regression with a standard test-negative design to estimate the vaccine effectiveness for preventing influenza-related hospitalizations.

RESULTS:

Among 4,755 hospitalized patients with COPD, 4,198 (88.3%) patients with known vaccination status were analyzed. The adjusted analysis showed a 38% reduction in influenza-related hospitalizations in vaccinated vs unvaccinated individuals. Influenza-positive patients (n = 1,833 [38.5%]) experienced higher crude mortality (9.7% vs 7.9%; P = .047) and critical illness (17.2% vs 12.1%; P < .001) compared with influenza-negative patients. Risk factors for mortality in influenza-positive patients included age > 75 years (OR, 3.7 [95% CI, 0.4-30.3]), cardiac comorbidity (OR, 2.0 [95% CI, 1.3-3.2]), residence in long-term care (OR, 2.6 [95% CI, 1.5-4.5]), and home oxygen use (OR, 2.9 [95% CI, 1.6-5.1]).

CONCLUSIONS:

Influenza vaccination significantly reduced influenza-related hospitalization among patients with COPD. Initiatives to increase vaccination uptake and early use of antiviral agents among patients with COPD could reduce influenza-related hospitalization and critical illness and improve health-care costs in this vulnerable population. TRIAL REGISTRY ClinicalTrials.govNo.NCT01517191; URL www.clinicaltrials.gov.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vacinas contra Influenza / Vacinação / Medição de Risco / Doença Pulmonar Obstrutiva Crônica / Influenza Humana / Hospitalização Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vacinas contra Influenza / Vacinação / Medição de Risco / Doença Pulmonar Obstrutiva Crônica / Influenza Humana / Hospitalização Idioma: En Ano de publicação: 2019 Tipo de documento: Article